Evidence map›Paper›PMID 41356351›Full record

ArticleResearch square2025

Dopamine receptor 1-expressing cells in the ventral hippocampus encode cocaine-context associations.

Veronika Kondev, Arthur Godino, Brian T Kipp, Evelyn Hennigan, Clara Casey, Vishwendra Patel, Sarah Naguib, Adam Ripp, Jacob Abroon, Liz Kahn and 10 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Veronika KondevNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Arthur GodinoNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-1732-1498
Brian T KippNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Evelyn HenniganDepartment of Psychiatry & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Clara CaseyDepartment of Psychiatry & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Vishwendra PatelNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Sarah NaguibHelen and Robert Appel Institute for Alzheimer's Disease Research, Brain and Mind Research Institute, Weill Cornell, New York, NY USA.
Adam RippNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jacob AbroonNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Liz KahnNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Isla RacineNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Earnest P ChenNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Clementine BlaschkeNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Angelica Minier-ToribioNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Molly EstillNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Alexa LaBancaNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Li GanHelen and Robert Appel Institute for Alzheimer's Disease Research, Brain and Mind Research Institute, Weill Cornell, New York, NY USA.ORCID 0000-0003-4600-275X
John F FullardDepartment of Psychiatry & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-9874-2907
Panos RoussosDepartment of Psychiatry & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-4640-6239
Eric J NestlerNash Family Department of Neuroscience & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-7905-2000

Funding

Transcription Factors in Stimulant and Opioid ActionP01DA047233 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YASMIN L. HURD · 2019 to 2026
$16.5M
Neurotrophic Mechanisms in Opiate and Cocaine ActionR01DA014133 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI ERIC J. NESTLER · 2000 to 2026
$12.1M
RESEARCH TRAINING - BIOLOGICAL SCIENCEST32MH014276 · NIMH · YALE UNIVERSITY · PI Marina R Picciotto · 1985 to 2026
$7.2M
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorderU01MH116442 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKBARIAN, SCHAHRAM, DRACHEVA, STELLA · 2018 to 2022
$5.9M
A regulome and transcriptome atlas of fetal and adult human neurogenesisRF1MH128970 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CAI, LONG, HOF, PATRICK R · 2021 to 2021
$5.5M
Epigenetic Mechanisms of Chronic Stress ActionR01MH129306 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ERIC J. NESTLER · 2023 to 2026
$2.7M
NIDA NIH HHS P01 DA047233NIDA NIH HHS R01 DA014133NIMH NIH HHS R01 MH129306NIMH NIH HHS RF1 MH128970NIMH NIH HHS T32 MH014276NIMH NIH HHS U01 MH116442
6 · The paper itself

Abstract

Dopamine (DA) signaling facilitates emotional valence, reward prediction error, and motivation; thus, dysfunctional dopamine signaling has been tied to several neuropsychiatric disorders, including substance use disorder (SUD). While most research has focused on striatal DA signaling, we and others have established that the ventral hippocampus (vHPC) also exhibits topographical organization of mostly non-overlapping dopaminoceptive neuronal populations: those expressing the DA receptor type 1 (D1) or type 2 (D2). Here, we use fiber photometry, optogenetics, and single nuclei RNA-sequencing (snRNA-seq) to explore how dopaminoceptive cells in the vHPC control cocaine-context memory expression. We reveal that vHPC D1 cells are inhibited by cocaine-conditioned contextual cues and that this inhibition is necessary and sufficient for reward-context associations driving cocaine conditioned place preference (CPP). Meanwhile vHPC D2 cells are not dynamically altered by learning but rather support positive reinforcement. Transcriptional changes induced by cocaine CPP encode these distinct functions, with D1 cells undergoing the greatest gene expression changes tied to synaptic signaling and plasticity. Together, these studies broaden our understanding of the role of DA within the larger mesocorticolimbic system and reveal new neuronal and circuit mechanisms underlying how drugs of abuse promote strong associative learning that could drive compulsive drug seeking characteristic of SUD.

Identifiers

PMID41356351
PMCPMC12676452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.